Inactive Instrument

SDS Biotech K.K. Share Price

Equities

4952

JP3163200003

Agricultural Chemicals

Dynamic Chart
Idemitsu Kosan Co.,Ltd. completed the acquisition of remaining 30.3% stake in SDS Biotech K.K. from group of sellers. CI
Idemitsu Kosan Co.,Ltd. entered into Share Exchange Agreement to acquire remaining 30.3% stake in SDS Biotech K.K. from group of sellers for ¥3.1 billion. CI
SDS Biotech K.K. Reports Earnings Results for the Second Quarter of 2021 CI
SDS Biotech K.K. Announces Consolidated Financial Results for the Nine Months Ended December 31, 2019; Provides Consolidated Financial Guidance for the Year Ending March 31, 2020 CI
SDS Biotech K.K. Announces Consolidated Earnings Results for the First Quarter Ended June 30, 2019; Provides Earnings Guidance for the Full Year Ending March 31, 2020; Provides Dividend Guidance for the Second Quarter of Fiscal Year 2020 and Full Year Ending March 31, 2020 CI
Sds Biotech K.K. Announces Consolidated Earnings Results for the Year Ended March 31, 2018 CI
R.Narasimhan, R.Padmanaban, R.Gopal completed the acquisition of an additional 97.95% stake in SDS Ramcides Cropscience Private Limited from SDS Biotech K.K.. CI
SDS Ramcides Cropscience Private Limited announced that it expects to receive INR 1.32 billion in funding from SDS Biotech K.K. CI
R.Narasimhan, R.Padmanaban, R.Gopal entered into an agreement to acquire additional 97.95% stake in SDS Ramcides Cropscience Private Limited from SDS Biotech K.K. for INR 0.21 million. CI
SDS Biotech K.K. Announces Consolidated Earnings Results for the Third Quarter Ended December 31, 2017; Provides Consolidated Earnings Guidance for the Full Year Ending March 31, 2018; Provides Dividend Guidance for the Year Ending March 31, 2018 CI
SDS Biotech K.K. Reports Consolidated Earnings Results for the Six Months Ended September 30, 2017; Provides Earnings Guidance for the Fiscal Year Ending March 31, 2018 CI
SDS Biotech K.K. Announces Consolidated Earnings Results for the First Quarter Ended June 30, 2017; Provides Consolidated Earnings Guidance for the Full Year Ending March 31, 2018; Provides Dividend Guidance for the Second Quarter and Full Year of Fiscal 2018 CI
SDS Biotech K.K. Reports Consolidated and Non-Consolidated Earnings Results for the Year Ended March 31, 2017; Announces Dividend for the Year Ended March 31, 2017, Payable on June 29, 2017; Provides Earnings Guidance for the Year Ending March 31, 2018; Provides Dividend Guidance for the Second Quarter and Fiscal Year 2018 CI
SDS Biotech K.K. Reports Consolidated Earnings Results for the Third Quarter Ended December 31, 2016; Revised Consolidated Earnings Guidance for the Full Year Ending March 31, 2017; Provides Dividend Guidance for the Full Year Ending March 31, 2017 CI
SDS Biotech K.K. Reports Consolidated Earnings Results for the Six Months Ended September 30, 2016; Provides Consolidated Earnings Guidance for the Year Ending March 31, 2017 CI
More news
Managers TitleAgeSince
President - -
Chief Administrative Officer - 31/03/91
Director/Board Member - 31/03/94
Members of the board TitleAgeSince
Director/Board Member 65 29/02/04
Director/Board Member - 31/03/86
Director/Board Member - 31/05/20
More insiders
SDS Biotech KK is a Japan-based company mainly engaged in the research, development, manufacture and sale of agricultural chemicals made by combining active ingredient, original substance and auxiliary ingredient into powder, granule, liquid and other dosage forms. The products include fungicides, rice herbicides, greening related agents and insecticides. Fungicides are drugs that protect crops from harmful effects of filamentous fungi, bacteria and other phytopathogenic fungi. Rice herbicide is a herbicide used for controlling weeds and rice cultivation. Greening related agents are drugs used in golf courses and parks, herbicides used in upland fields, and plant growth regulators that enhance or inhibit the physiological functions of plants. Insecticides are agents used to control insect pests that damage crops. The Company also provides industrial fungicides. The Company operates within the domestic market and to overseas markets, including Asia, North America, Europe and Oceania.
More about the company